We are the world’s first patient led recruitment platform dedicated to connecting rare disease patients with clinical trials, we place patients at the heart of everything we do. Our mission is simple yet impactful: to bridge the gap between underserved rare disease communities and cutting-edge research. By empowering patients to lead the way, we create a space where their voices are not just heard but drive meaningful change in medical innovation. We understand the unique challenges rare disease patients face. That’s why our platform is built to provide transparency, trust, and ease of access to clinical trials tailored to their needs. Traditional recruitment methods often leave rare disease patients behind. Our data-driven, patient-first approach ensures trials reach the right participants at the right time, accelerating breakthroughs in research. We foster collaboration between patients, caregivers, researchers, and pharmaceutical companies, uniting diverse voices to bring rare disease treatments to light. By revolutionizing recruitment, we aim to not only advance clinical trials but also cultivate hope and tangible outcomes for patients and families worldwide. Whether you're a patient, caregiver, researcher, or industry professional, we invite you to join us on this journey. Together, we can create a future where rare is no longer an obstacle to treatment.
Looking for a particular TrialSync employee's phone or email?
Anders Berenth is the Co-founder and Chief Product Officer of TrialSync.
2 people are employed at TrialSync.